Showing results (621-630 of 653) with videos related to
Sort By:
Pageof 66
Annals of Gastroenterological Surgery|November 6, 2023
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial)Ken-Ichi Okada, Kenjiro Kimura, Yo-Ichi Yamashita, et al.Surgery Today|June 4, 2020
Is there disparity between regions and facilities in surgical resident training in Japan? Insights from a national surveyDaisuke Hashimoto, Saseem Poudel, Satoshi Hirano, et al.International Journal of Cancer|August 27, 2014
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograftGewen Tan, Hideki Kasuya, Tevfik Tolga Sahin, et al.Journal of Gastroenterology|March 4, 2020
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignanciesKazuyuki Mizuno, Takanori Ito, Masatoshi Ishigami, et al.Surgery Today|March 4, 2020
Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in JapanSaseem Poudel, Satoshi Hirano, Yo Kurashima, et al.World Journal of Hepatology|September 24, 2016
Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantationTomohide Hori, Yasuhiro Ogura, Yasuharu Onishi, et al.Surgery Today|May 19, 2019
A snapshot of surgical resident training in Japan: results of a national-level needs assessment surveySaseem Poudel, Satoshi Hirano, Yo Kurashima, et al.Nagoya Journal of Medical Science|June 27, 2019
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II studyNao Takano, Suguru Yamada, Akihiro Hirakawa, et al.Cancer Medicine|March 31, 2023
Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classificationMasanori Nakamura, Yukiyasu Okamura, Keiichi Ohshima, et al.The Oncologist|July 28, 2018
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)Goro Nakayama, Ayako Mitsuma, Yuki Sunagawa, et al.Pageof 66